BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36323697)

  • 1. LncRNAs as biomarkers for predicting radioresistance and survival in cancer: a meta-analysis.
    Xie Y; Han J; Xie K; Gou Q
    Sci Rep; 2022 Nov; 12(1):18494. PubMed ID: 36323697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic and prognostic value of exosome-derived long non-coding RNAs in cancer patients: a meta-analysis.
    Mu H; Zhang S; Yao Z; Liu Y; Lin K; Zhao Z; Zhu Y
    Clin Exp Med; 2020 Aug; 20(3):339-348. PubMed ID: 32504320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis.
    Xia Y; Liu Z; Yu W; Zhou S; Shao L; Song W; Liu M
    PLoS One; 2018; 13(6):e0198602. PubMed ID: 29870555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of exosomal noncoding RNA in hepatocellular carcinoma: a meta-analysis.
    Nie G; Lian N; Peng D; Lu J; Li B
    Carcinogenesis; 2022 Sep; 43(8):754-765. PubMed ID: 35904534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Long Noncoding RNAs in Patients with Gastrointestinal Cancer: A Systematic Review and Meta-Analysis.
    Kang W; Zheng Q; Lei J; Chen C; Yu C
    Dis Markers; 2018; 2018():5340894. PubMed ID: 30598708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA as promising theragnostic biomarkers for predicting radioresistance in cancer: A systematic review and meta-analysis.
    Mohammadi C; Gholamzadeh Khoei S; Fayazi N; Mohammadi Y; Najafi R
    Crit Rev Oncol Hematol; 2021 Jan; 157():103183. PubMed ID: 33310279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNAs as Theragnostic Biomarkers for Predicting Radioresistance in Cancer: A Systematic Review and Meta-Analysis.
    Lin P; Xing W; Ren Q; Wang Q; Yan J; Mao G
    Front Oncol; 2022; 12():767750. PubMed ID: 35692742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis.
    Qin J; Ke B; Liu T; Kong C; Li A; Fu H; Jin C
    Cancer Med; 2023 Feb; 12(3):2199-2218. PubMed ID: 36057947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic value of lncRNAs expression in gastric cancer: A field synopsis of observational studies and databases validation.
    Xu X; Duan F; Ng S; Wang H; Wang K; Li Y; Niu G; Xu E
    Medicine (Baltimore); 2022 Oct; 101(40):e30817. PubMed ID: 36221326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis.
    Zhong Y; Chen Z; Guo S; Liao X; Xie H; Zheng Y; Cai B; Huang P; Liu Y; Zhou Q; Liu Y; Huang W
    Medicine (Baltimore); 2017 Nov; 96(46):e8583. PubMed ID: 29145271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNAs in bladder cancer prognosis: A meta-analysis.
    Zhu W; Liu H; Wang X; Lu J; Yang W
    Pathol Res Pract; 2019 Jun; 215(6):152429. PubMed ID: 31064722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of abnormally expressed lncRNAs in ovarian carcinoma: a systematic review and meta-analysis.
    Luo P; Liu XF; Wang YC; Li ND; Liao SJ; Yu MX; Liang CZ; Tu JC
    Oncotarget; 2017 Apr; 8(14):23927-23936. PubMed ID: 28118613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of lncRNAs in regulating cancer cell radiosensitivity.
    Zhu J; Chen S; Yang B; Mao W; Yang X; Cai J
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31391206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analyses of long noncoding RNA expression profiles correlated with radioresistance in nasopharyngeal carcinoma via next-generation deep sequencing.
    Li G; Liu Y; Liu C; Su Z; Ren S; Wang Y; Deng T; Huang D; Tian Y; Qiu Y
    BMC Cancer; 2016 Sep; 16(1):719. PubMed ID: 27599611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of altered long noncoding RNAs in overall survival of ovarian cancer: A systematic review and meta-analysis.
    Seyed Hosseini E; Alizadeh Zarei M; Haddad Kashani H; Milajerdi A; Zare Dehghanani Z; Hassani Bafrani H; Nikzad H
    Pathol Res Pract; 2021 Mar; 219():153363. PubMed ID: 33621920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormally expressed lncRNAs in the prognosis and clinicopathology of oesophageal cancer: a systematic review and meta-analysis.
    Qian P; Xu Z; Chen H; Yue S; Lv Y
    J Genet; 2020; 99():. PubMed ID: 32529986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p.
    Sun Y; Wang J; Ma Y; Li J; Sun X; Zhao X; Shi X; Hu Y; Qu F; Zhang X
    J Exp Clin Cancer Res; 2021 Sep; 40(1):306. PubMed ID: 34587992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
    Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
    [No Abstract]   [Full Text] [Related]  

  • 20. Change of Circulating and Tissue-Based miR-20a in Human Cancers and Associated Prognostic Implication: A Systematic Review and Meta-Analysis.
    Zhang Q; Wang Q; Sun W; Gao F; Liu L; Cheng L; Li Z
    Biomed Res Int; 2018; 2018():6124927. PubMed ID: 30596096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.